Scientists create a biomedical tattoo to monitor for a sign of cancer
A biomedical tattoo that changes color when calcium in the blood is too high could one day be used to monitor for the earliest signs of cancer, scientists report in a new study. Source: Read more
Adding Allopurinol Safe, Effective in IBD
Adjunctive allopurinol is safe, effective, and well tolerated in inflammatory bowel disease (IBD) patients who do not respond adequately to thiopurines due to hypermethylation, a randomized Read more
90-day CGM implant receives recommendation for FDA approval
Eversense, a continuous glucose monitor from Senseonics that is implanted subcutaneously in the arm for up to three months, has been recommended for approval by an FDA advisory committee. Read more
Malnourished Patients Fall Through the Cracks in America’s Hospitals
A persistent lack of awareness about the dangers of malnutrition among patients is contributing to higher mortality rates and longer hospital stays. Source: Malnourished Patients Fall Read more
DPP-4I Not Tied to Increased Risk of Acute Pancreatitis in Seniors
Among adults with heart disease, risk increased with DPP-4I versus thiazolidinedione not sulfonylureas Source: DPP-4I Not Tied to Increased Risk of Acute Pancreatitis in Read more
Another Bariatric Benefit: Improved Albuminuria
Among a cohort of 101 patients with albuminuria who had bariatric surgery at the Cleveland Clinic from 2005 to 2014 and were followed for 4 to 10 years, 80% had overall improvement in their Read more
Serum Bicarbonate Tied to CKD Progression
Another use for multivariate risk equations Source: Serum Bicarbonate Tied to CKD Read more
Clinical Practices to Mitigate Weight Bias
This article reviews the evidence for how the attitudes, communication, and behaviors of clinicians differ towards patients with obesity, and examines interventions to reduce weight bias Read more
The Paradox of Behavior Change
The natural tendency of life is to find stability. In biology we refer to this process as equilibrium or homeostasis. Source: The Paradox of Behavior Read more
SGLT-2 Inhibitors: The Best Bet Among New T2D Drugs?
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors came out on top in a large meta-analysis of clinical trials that compared the newer classes of diabetes drugs head-to-head in terms of Read more